HawaiiSR 42025–2026 Regular Session (Year 1)Senate

REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

Sponsored By: Kurt Fevella (Republican)

In Committee

HealthMedicaidInsuranceKetamine TherapyAuditorReportHHS, WAM

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Kurt Fevella

    Republican • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. The committee on HHS deferred the measure.

    3/24/2025Senate
  2. The committee(s) on HHS has scheduled a public hearing on 03-24-25 1:05PM; Conference Room 225 & Videoconference.

    3/20/2025Senate
  3. Referred to HHS, WAM.

    2/3/2025Senate
  4. Offered.

    1/30/2025Senate

Bill Text

Related Bills

Back to State Legislation